A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes (opens ClinicalTrials.gov)
- Sponsor
- Hoffmann-La Roche
- Enrolment
- 330
- Started
- 2025-08-19
- Last update
- 2026-10-01
Conditions: Type 2 Diabetes Mellitus
Interventions: RO7795081, Semaglutide, Placebo